Elizabeth Varki Jobes - 01 Mar 2022 Form 4 Insider Report for Ampio Pharmaceuticals, Inc.

Role
Director
Signature
/s/ Dan Stokely, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
01 Mar 2022
Net transactions value
$0
Form type
4
Filing time
02 Mar 2022, 14:12:25 UTC
Previous filing
02 Mar 2022
Next filing
11 Jan 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AMPE Stock Option (Right to Buy) Award $0 +150,000 $0.000000 150,000 01 Mar 2022 Common Stock 150,000 $0.4513 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock options vest as to 1/36 of the underlying shares monthly on the 24th day of each month for three years (until February 24, 2025). The vesting commencement date is February 24, 2022